262 related articles for article (PubMed ID: 20663324)
1. Correlation analysis between loss of heterozygosity at chromosome 18q and prognosis in the stage-II colon cancer patients.
Wang W; Li YF; Sun XW; Chen G; Zhan YQ; Huang CY; Wan DS; Pan ZZ; Zhou ZW
Chin J Cancer; 2010 Aug; 29(8):761-7. PubMed ID: 20663324
[TBL] [Abstract][Full Text] [Related]
2. Prognostic values of chromosome 18q microsatellite alterations in stage II colonic carcinoma.
Wang W; Wang GQ; Sun XW; Chen G; Li YF; Zhang LY; Qiu HB; Huang CY; Zhan YQ; Zhou ZW
World J Gastroenterol; 2010 Dec; 16(47):6026-34. PubMed ID: 21157981
[TBL] [Abstract][Full Text] [Related]
3. Allelic loss on chromosome 18q as a prognostic marker in stage II colorectal cancer.
Martínez-López E; Abad A; Font A; Monzó M; Ojanguren I; Pifarré A; Sánchez JJ; Martín C; Rosell R
Gastroenterology; 1998 Jun; 114(6):1180-7. PubMed ID: 9609754
[TBL] [Abstract][Full Text] [Related]
4. Confirmation that chromosome 18q allelic loss in colon cancer is a prognostic indicator.
Ogunbiyi OA; Goodfellow PJ; Herfarth K; Gagliardi G; Swanson PE; Birnbaum EH; Read TE; Fleshman JW; Kodner IJ; Moley JF
J Clin Oncol; 1998 Feb; 16(2):427-33. PubMed ID: 9469325
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of 18q LOH in sporadic colorectal carcinoma.
Pilozzi E; Ferri M; Onelli MR; Mercantini P; Corigliano N; Duranti E; Dionisi L; Felicioni F; Virgilio E; Ziparo V; Ruco L
Am Surg; 2011 Jan; 77(1):38-43. PubMed ID: 21396303
[TBL] [Abstract][Full Text] [Related]
6. Loss of heterozygosity on chromosome 18q in cohesive-type gastric cancer is associated with tumor progression and poor prognosis.
Inoue T; Uchino S; Shiraishi N; Adachi Y; Kitano S
Clin Cancer Res; 1998 Apr; 4(4):973-7. PubMed ID: 9563892
[TBL] [Abstract][Full Text] [Related]
7. A novel multiplexing, polymerase chain reaction-based assay for the analysis of chromosome 18q status in colorectal cancer.
Erill N; Colomer A; Calvo M; Vidal A; Román R; Verdú M; Cordón-Cardó C; Puig X
J Mol Diagn; 2005 Oct; 7(4):478-85. PubMed ID: 16237217
[TBL] [Abstract][Full Text] [Related]
8. Association between recurrence of sporadic colorectal cancer, high level of microsatellite instability, and loss of heterozygosity at chromosome 18q.
Sarli L; Bottarelli L; Bader G; Iusco D; Pizzi S; Costi R; D'Adda T; Bertolani M; Roncoroni L; Bordi C
Dis Colon Rectum; 2004 Sep; 47(9):1467-82. PubMed ID: 15486743
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance and molecular associations of 18q loss of heterozygosity: a cohort study of microsatellite stable colorectal cancers.
Ogino S; Nosho K; Irahara N; Shima K; Baba Y; Kirkner GJ; Meyerhardt JA; Fuchs CS
J Clin Oncol; 2009 Sep; 27(27):4591-8. PubMed ID: 19704056
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of loss of heterozygosity and sub-cellular localization of SMAD4 varies with tumor stage in colorectal cancer.
Jia X; Shanmugam C; Paluri RK; Jhala NC; Behring MP; Katkoori VR; Sugandha SP; Bae S; Samuel T; Manne U
Oncotarget; 2017 Mar; 8(12):20198-20212. PubMed ID: 28423626
[TBL] [Abstract][Full Text] [Related]
11. Adenocarcinoma of the ampulla of Vater: T-stage, chromosome 17p allelic loss, and extended pancreaticoduodenectomy are relevant prognostic factors.
Iacono C; Verlato G; Zamboni G; Scarpa A; Montresor E; Capelli P; Bortolasi L; Serio G
J Gastrointest Surg; 2007 May; 11(5):578-88. PubMed ID: 17468917
[TBL] [Abstract][Full Text] [Related]
12. Microsatellite instability and loss of heterozygosity at chromosomal location 18q: prospective evaluation of biomarkers for stages II and III colon cancer--a study of CALGB 9581 and 89803.
Bertagnolli MM; Redston M; Compton CC; Niedzwiecki D; Mayer RJ; Goldberg RM; Colacchio TA; Saltz LB; Warren RS
J Clin Oncol; 2011 Aug; 29(23):3153-62. PubMed ID: 21747089
[TBL] [Abstract][Full Text] [Related]
13. Loss of 18q predicts poor survival of patients with squamous cell carcinoma of the head and neck.
Pearlstein RP; Benninger MS; Carey TE; Zarbo RJ; Torres FX; Rybicki BA; Dyke DL
Genes Chromosomes Cancer; 1998 Apr; 21(4):333-9. PubMed ID: 9559345
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of K-ras mutations and allelic imbalance on chromosome 18q in patients with resected colorectal cancer.
Font A; Abad A; Monzó M; Sanchez JJ; Guillot M; Manzano JL; Piñol M; Ojanguren I; Rosell R
Dis Colon Rectum; 2001 Apr; 44(4):549-57. PubMed ID: 11330582
[TBL] [Abstract][Full Text] [Related]
15. 18q loss of heterozygosity in microsatellite stable colorectal cancer is correlated with CpG island methylator phenotype-negative (CIMP-0) and inversely with CIMP-low and CIMP-high.
Ogino S; Kawasaki T; Kirkner GJ; Ohnishi M; Fuchs CS
BMC Cancer; 2007 May; 7():72. PubMed ID: 17474983
[TBL] [Abstract][Full Text] [Related]
16. Molecular predictors of survival after adjuvant chemotherapy for colon cancer.
Watanabe T; Wu TT; Catalano PJ; Ueki T; Satriano R; Haller DG; Benson AB; Hamilton SR
N Engl J Med; 2001 Apr; 344(16):1196-206. PubMed ID: 11309634
[TBL] [Abstract][Full Text] [Related]
17. Poorly differentiated adenocarcinoma and mucinous carcinoma of the colon and rectum show higher rates of loss of heterozygosity and loss of E-cadherin expression due to methylation of promoter region.
Kanazawa T; Watanabe T; Kazama S; Tada T; Koketsu S; Nagawa H
Int J Cancer; 2002 Nov; 102(3):225-9. PubMed ID: 12397640
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of DNA ploidy in patients with stage II and stage III colon carcinoma: a prospective flow cytometric study.
Lanza G; Gafà R; Santini A; Maestri I; Dubini A; Gilli G; Cavazzini L
Cancer; 1998 Jan; 82(1):49-59. PubMed ID: 9428479
[TBL] [Abstract][Full Text] [Related]
19. Chromosome 18q allelic loss and prognosis in stage II and III colon cancer.
Lanza G; Matteuzzi M; Gafá R; Orvieto E; Maestri I; Santini A; del Senno L
Int J Cancer; 1998 Aug; 79(4):390-5. PubMed ID: 9699532
[TBL] [Abstract][Full Text] [Related]
20. Loss of heterozygosity on chromosomes 2p, 3p, 18q21.3 and 11p15.5 as a poor prognostic factor in stage II and III (FIGO) cervical cancer treated by radiotherapy.
Kozlowski L; Filipowski T; Rucinska M; Pepinski W; Janica J; Skawronska M; Poznanski J; Wojtukiewicz MZ
Neoplasma; 2006; 53(5):440-3. PubMed ID: 17013540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
